Okyo Pharma Ltd
Nasdaq OKYO · London, United Kingdom
Works in Neurology · Ophthalmology
Okyo Pharma Ltd is a clinical trial sponsor based in London, United Kingdom, listed as Nasdaq OKYO. It has 1 active clinical trial with 111 planned participants, in Neurology and Ophthalmology. Since 2021 it has completed 1 trial and stopped 1 early.
Trial track record · since 2021
Financials · Nasdaq OKYO
Fundraising
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Okyo Pharma Ltd
Okyo Pharma Ltd is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 111 planned participants, in Neurology, Ophthalmology. Since 2021 it has completed 1 trial and stopped 1 early.
Okyo Pharma Ltd is based in London, United Kingdom and is listed as Nasdaq OKYO. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Okyo Pharma Ltd; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-29.
Approve Suite is not affiliated with Okyo Pharma Ltd.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.